|
|
||||||||
Department of Pediatrics, Division of Perinatal Medicine, University of Colorado School of Medicine, Aurora, CO 80045-0508
| Abstract |
|---|
|
|
|---|
Key Words: fetal polyols fetal-maternal gradients ovine placental polyols myo-inositol mannose sorbitol fructose
| Introduction |
|---|
|
|
|---|
The present study utilizes the HPLC technique with selected carbohydrate columns to identify hexoses and their polyols in fetal and maternal circulations perfusing the placenta and in placental tissue. The concentrations were quantified at micromolar levels and were coupled with uterine and umbilical blood flow measurements so that uptakes could be calculated. All the polyols identified were further confirmed with gas chromatography (GC)/mass spectrometry (MS).
| Materials and Methods |
|---|
|
|
|---|
One hour before the sampling, either ethanol (25.7 ml of absolute ethanol dl-1) at a rate of 0.03 ml kg-1 min-1, or 400 µCi of titrated water at a rate of 0.83 µCi/min (Amersham, Arlington Heights, IL) for a total volume of 3.6 ml over 2 hr was infused into the fetus to determine uterine and umbilical blood flows by the steady-state diffusion technique (14). Four sets of blood samples were drawn simultaneously at 30-min intervals into heparinized syringes from the maternal artery, uterine vein, fetal artery, and umbilical vein. Hemoglobin and O2 saturation were measured spectrophotometrically (OSM-3 Radiometer, Copenhagen, Denmark). Plasma-tritiated water concentrations were determined by liquid scintillation counting using a Packard Tri-Carb 2300TR liquid scintillation counter. Plasma ethanol concentrations were measured spectrophotometrically using ethanol dehydrogenase. The blood samples for carbohydrate measurement were centrifuged at 4°C and were stored as plasma in a -70°C freezer until HPLC analysis. At the time of necropsy, the animals were anesthetized with an i.v. injection of Diazepam (0.11 mg/kg body weight)-ketamine (4.4 mg/kg body weight) and the uterus was removed. The animals were then injected with 12 ml of Sleepaway (Fort Dodge Animal Health, Fort Dodge, IA). At necropsy, catheter locations were confirmed, and fetal and placental weights were obtained. The cotyledons were separated from the placentomes manually, and were weighed, frozen in liquid nitrogen, and stored at -70°C. The percentage of water in the cotyledons was determined by drying to constant weight.
HPLC Analysis.
The plasma was thawed quickly and deproteinization was achieved as follows: 0.1 ml of 0.3 N zinc sulfate containing 30 mg% xylitol as internal standard was added to 0.1 ml of plasma, the mixture was mixed well, and 0.1 ml of 0.3 N barium hydroxide was added. The mixture was centrifuged at 14,000g for 10 min and the supernatant was filtered through a 0.45-µm filter before loading on a refrigerated autosampler for HPLC analysis. For tissue analysis, cotyledons from six animals were used. The cotyledons were thawed, homogenized, and sonicated in distilled water at 4°C. After centrifuging, the tissue supernatant was deproteinized and analyzed as for plasma. On tissue samples, a separate analysis without the addition of xylitol as internal standard was performed to quantify the tissue concentration of xylitol in tissue.
A Dionex HPLC analyzer equipped with a CarboPac MA1 anion-exchange column was used for the separation of the hexoses and polyols (Dionex, Sunnyvale, CA). The analysis was run isocratically with 500 mM sodium hydroxide for 25 min, followed by a step change to 400 mM sodium hydroxide for 20 min at ambient temperature. The flow rate was 0.4 ml/hr. The sodium hydroxide solution was prepared with degassed, deionized water. All the peaks were quantified using a pulse amperometric detector with a gold working electrode (14). The Dionex PeakNet software was used for instrument operation and data analysis. The concentrations of each sugar were calculated by using the integrated area under the peak. The internal xylitol standard was used to correct for instrument variances with the equation: Concentration (in µM) = (Au/As) K D (Xs/Xu).
GC-MS.
Plasma samples and placental tissues previously homogenized and sonicated were deproteinized with absolute ethanol. The ethanol mixture was centrifuged, the supernatant was evaporated, and the residue was redissolved in water. The solution was passed on a DEAE Sephadex A-25 anion exchange resin, eluted with water, and the eluate was evaporated to dryness (16). The dried samples were then derivatized and analyzed by gas liquid chromatography and MS as described for the authentic carbohydrates below.
Authentic carbohydrates were converted to their alditol acetates and trimethysilyl (TMS) derivatives. Alditol acetates were prepared by reducing the carbohydrates with sodium borohydride, followed by acetylation (17, 18). TMS derivatives were obtained by dissolving the dry sugar residue in warm pyridine (for approximately 10 min), followed by derivatizing with hexamethyldisilazane (HMDS) and trimethylchlorosilane (TMCS) at room temperature for 2 hr or more (pyridine:HMDS:TMCS, 5:2:1, v/v) (19). Precipitate was removed by centrifugation, the supernatant was evaporated, and the residue was redissolved in a mixture of bis(trimethylsilyl)trifluoroacetamide (BSTFA) containing 1% TMCS and acetonitrile (BSTFA/TMCS, acetonitrile, 1:5, v/v).
Gas Liquid Chromatography/MS.
The derivatized samples were analyzed by GC-MS and the sugars were identified on GC by comparing their relative indices (methylene units) to those of the authentic carbohydrates as well as by their mass spectra.
The GC was performed on a capillary gas chromatograph (Carlo Erba) fitted with a DB1 column (30 m by 0.25 mm o.d.) as described earlier (17). The oven was held for 4 min at an isothermal temperature of 160°C (or lower, i.e., 110°C for the low-molecular-weight carbohydrates) and was then programmed to 250°C at 1°C/min.
Mass spectra were obtained on a Hewlett Packard (Palo Alto, CA) 5790 mass spectrometer (MSD) with the same temperature settings as for the GC. Ethanol concentrations were determined using Sigma (St. Louis, MO) diagnostic kit.
Calculations and Statistics.
Uterine (Qm) and umbilical (Qf) blood flows were calculated by the application of the steady-state transplacental diffusion method with either ethanol or tritiated water as a flow-limited marker (14). The plasma flows were calculated from the blood flow: plasma flow = blood flow x (1 - Ht), where Ht is the hematocrit; the umbilical and uterine plasma uptakes of carbohydrates were calculated by the application of the Fick principle: umbilical plasma uptake = Qf (
-
)plasma, where
and
refer to umbilical venous and umbilical arterial plasma concentrations; and uterine plasma uptake = Qm (A - V)plasma, where A and V refer to maternal artery and uterine vein plasma concentrations. All the values were expressed as µMmin-1kg fetus-1. All data are expressed as mean and standard error (SE). The maternal and fetal concentration differences were tested by analysis of variance (ANOVA) with two fixed effects (two types of vessels by two circulations) and one random effect (28 animals). The P values for the maternal-fetal concentration differences are presented in Table I
. The uterine and umbilical uptakes were analyzed for significance from 0 by using paired student
test after testing for a normal distribution. Two-tailed values were considered significance at P < 0.05.
|
| Results |
|---|
|
|
|---|
|
|
5-fold that of fetal glucose concentrations. The fetal artery/maternal artery concentration ratios for all compounds are presented in Table I
|
|
|
|
| Discussion |
|---|
|
|
|---|
These advantages permit the accurate measurement of many polyols and hexoses in blood and placental tissue at the micromolar level. In the pregnant sheep, glucose, fructose, sorbitol, myo-inositol, and glycerol had been reported previously in fetal blood (15). However, this is the first demonstration that there is a net release of sorbitol into both circulations, which establishes the fact that there is placental sorbitol production in vivo. The sorbitol pathway for production from glucose using aldose reductase has been shown to be present in human umbilical cord tissue (9). The present study presents fetal/maternal concentration ratios of the polyols in plasma. These ratios are surprising and much higher than those found for any amino acids. The high fetal and placental concentrations of the polyols, particularly erythritol (
65-fold higher in fetal plasma) and ribitol (
100-fold higher), have not been reported previously. This finding suggests production of polyols within the conceptus (fetus and placenta) and a very low permeability from the placenta into the maternal circulation. Enzymatic studies of the aldose reductases for these polyols and tracer studies will be required to confirm this hypothesis and to establish the primary site of synthesis (fetus versus placenta). The presence of so many polyols in the fetal circulation may reflect a difference in redox state of fetal versus maternal tissues. This relationship to redox state and the high polyol concentrations in fetal tissues was pointed out by Toh et al. (11). The reduced redox state of fetal tissues was pointed out by several early studies of lactate/pyruvate ratios in fetal tissues (11). However, the redox state, although accounting for increased polyol production, does not explain the maintenance of such large maternal-fetal concentration gradients.
The fact that there is no significant umbilical uptake of fructose is due to two factors. First, the very high fetal fructose concentrations could mask a significant fetal uptake because of a low coefficient of extraction (CE). For example, a 2% CE across the umbilical circulation would not be detectable by these techniques, yet it would represent a venoarterial concentration difference of 150 µM, a very significant value nutritionally. Second, ovine placental tissue has been shown to have a high aldose reductase activity, but a relatively low sorbitol dehydrogenase activity (2). The data in the present report are consistent with the enzymatic studies given the current findings of a relatively high placental sorbitol concentration and low fructose concentration compared with fetal plasma.
The finding that despite a low maternal concentration of mannose (4.6 µM), there is a significant uptake of mannose into the placenta from the maternal circulation and a significant uptake into the fetal circulation suggests there may be a mannose transporter in the trophoblast, as had been described for other tissues (20). The studies of mannose affinity for glucose transporters had described a very low affinity compared with glucose (21). Since glucose concentration in the maternal circulation is much higher than mannose, the in vivo data suggest the presence of a specific mannose transporter. The umbilical uptake of mannose may be important for the fetus despite the fact that theoretically mannose requirements could be met by mannose synthesis from glucose. Recent studies with human fibroblasts have shown that an external source of mannose is used preferentially for N-glycosylation rather than mannose produced from glucose (21). This may also be true for fetal tissues, heightening the importance of an umbilical uptake of mannose. The placental supply of mannose may meet the fetal requirements.
It is surprising that the placenta is able to maintain a fetal/maternal concentration ratio of close to 60-fold for erythritol given the fact that erythritol is a relatively small neutral molecule. It suggests that the ovine placenta is relatively impermeable to erythritol.
| Footnotes |
|---|
1 To whom requests for reprints should be addressed at Fitzsimons, Building 260, 13243 E. 23rd Avenue, Aurora, CO 80010. ![]()
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Jozwik, M. Jozwik, C. Teng, and F. C. Battaglia Concentrations of monosaccharides and their amino and alcohol derivatives in human preovulatory follicular fluid Mol. Hum. Reprod., November 1, 2007; 13(11): 791 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C Battaglia Placental transport: a function of permeability and perfusion Am. J. Clinical Nutrition, February 1, 2007; 85(2): 591S - 597S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Burkhardt, M. P. Jimenez de Bagues, J.-P. Liautard, and S. Kohler Analysis of the Behavior of eryC Mutants of Brucella suis Attenuated in Macrophages Infect. Immun., October 1, 2005; 73(10): 6782 - 6790. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Jauniaux, J. Hempstock, C. Teng, F. C. Battaglia, and G. J. Burton Polyol Concentrations in the Fluid Compartments of the Human Conceptus during the First Trimester of Pregnancy: Maintenance of Redox Potential in a Low Oxygen Environment J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1171 - 1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Lavrentyev, D. He, and G. A. Cook Expression of genes participating in regulation of fatty acid and glucose utilization and energy metabolism in developing rat hearts Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2035 - H2042. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |